Becton, Dickinson and Company vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
6.7
Neutral
Quality
Health
Growth
Valuation
Sentiment
BDX
Consensus analyst target of $191.46 is 28% above current price.
⚠ analyst sentiment is cautious.
MRK
Forward P/E of 11.5× is low relative to sector peers.
Analyst Consensus
HOLD
Target $191.46 (+28.2%)
13 analysts
BUY
Target $129.74 (+15.7%)
27 analysts
Fundamentals
BDX
MRK
24.4×
Trailing P/E
31.5×
11.1×
Forward P/E
11.5×
8.0%
Profit Margin
13.6%
46.8%
Gross Margin
76.6%
7.0%
ROE
—
1.6%
Revenue Growth
4.9%
28.6%
Earnings Growth
—
0.35
Beta
0.28
—
Price / Book
—
$42.5B
Market Cap
$277.0B
$128 – $187
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →